{"nct_id":"NCT00378482","title":"A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.","status":"COMPLETED","status_verified_date":"2024-08","start_date":"2007-03-05","start_date_type":"ACTUAL","primary_completion_date":"2023-10-27","primary_completion_date_type":"ACTUAL","completion_date":"2023-10-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AZN"]}